As of today (2024-04-25), the Forward Annual Dividend Yield of Amgen is 3.30%.
As of today (2024-04-25), the Trailing Annual Dividend Yield of Amgen is 3.18%.
AMGN's Forward Dividend Yield % is ranked better than 74.14% of 495
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs AMGN: 3.30
Amgen's Dividends per Share for the
three
months ended in Dec. 2023 was $2.13.
During the past 12 months, Amgen's average Dividends Per Share Growth Rate was 9.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 10.00% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.10% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 15.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Amgen was 63.30% per year. The lowest was 10.00% per year. And the median was 15.95% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Competitive Comparison of Amgen's Forward Dividend Yield %
For the Drug Manufacturers - General subindustry, Amgen's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amgen's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Amgen's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Amgen's Forward Dividend Yield % falls into.
Amgen Forward Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Amgen Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 2.250
2024-02-15
2024-02-16
2024-03-07
Cash Dividend
quarterly
USD:USD 1.000000
USD 2.130
2023-11-16
2023-11-17
2023-12-08
Cash Dividend
quarterly
USD:USD 1.000000
USD 2.130
2023-08-17
2023-08-18
2023-09-08
Cash Dividend
quarterly
USD:USD 1.000000
USD 2.130
2023-05-17
2023-05-18
2023-06-08
Cash Dividend
quarterly
USD:USD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Amgen's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
9
/
273.01
=
3.30 %
Current Share Price is $273.01.
Amgen's Dividends per Share for the forward twelve months is calculated as $2.25 * 4 = $9.
Amgen's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
8.64
/
273.01
=
3.16 %
Current Share Price is $273.01.
Amgen's Dividends per Share for the trailing twelve months (TTM) ended in Today is $8.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Thank you for viewing the detailed overview of Amgen's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMGN has been successfully added to your